EUVIMEDEUVIMED entdecken
Crossref

1861-P: Performance of DBLG1 System for Aerobic, Anaerobic, and Mixed Type Physical Activities

ALICE ADENIS, SYLVAIN LACHAL, PIERRE GAUTHIER, PAUL GIMENEZ, CHESNER DESIR, THIBAULT LE ROUX-MALLOUF, ERIK HUNEKER, PIERRE Y. BENHAMOU

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-1861-p ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von ALICE ADENIS und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Physical activity (PA) impacts glucose variability differently depending on the activity type. The DBLG1 System utilizes distinct target adjustments for Aerobic (+70 mg/dL), Mixed (+40), and Anaerobic (+20) activities. We evaluated the efficacy of these types by analyzing declared sessions, excluding generic “Sport” declarations to ensure physiological accuracy.

Methods

We analyzed 8,358 PA sessions (Aerobic, Anaerobic or Mixed) from 982 adult users. We compared glycemic outcomes during the PA to matched non-PA control periods (shifted 24/48 hour). Metrics included Time Above Range (TAR >180 mg/dL) and Rescue Carbs (RC) consumption.

Results

The algorithm demonstrated effective control for Anaerobic PA despite the lower target increase (Table 1): TAR increased by only 2.9 percentage points (pp) with minimal RC increase (+2.3 g). Conversely, Mixed PA was the most challenging: despite the intermediate target, they were associated with the largest TAR increase (+6.5 pp) and the highest RC increase (+4.1 g). Aerobic activities showed intermediate results (+3.6 pp TAR).

Conclusion

The target strategy effectively prevents hypoglycemia. Mixed PA remains prone to hyperglycemia and high carbohydrate intake. The unpredictability of Mixed PA, combined with preventive snacking, could benefit from further algorithmic adaptations. Future improvements could consider PA type not just for target adjustment, but also to tailor RC recommendations to the specific PA type. Disclosure A. Adenis: Employee; Current; Diabeloop SA. S. Lachal: Employee; Current; Diabeloop SA. P. Gauthier: Employee; Current; Diabeloop SA. P. Gimenez: Employee; Current; Diabeloop SA. C. Desir: Employee; Current; Diabeloop SA. T. Le Roux-Mallouf: None. E. Huneker: Employee; Current; Diabeloop SA. P.Y. Benhamou: Employee; Current; Diabeloop SA. Advisory Panel; Ended; Eli Lilly and Company, Novo Nordisk.

Zitieren

APA

ADENIS, A., LACHAL, S., GAUTHIER, P., GIMENEZ, P., DESIR, C., ROUX-MALLOUF, T. L., HUNEKER, E., & BENHAMOU, P. Y. (2026). 1861-P: Performance of DBLG1 System for Aerobic, Anaerobic, and Mixed Type Physical Activities. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-1861-p

Vancouver

ADENIS A, LACHAL S, GAUTHIER P, GIMENEZ P, DESIR C, ROUX-MALLOUF TL, et al. 1861-P: Performance of DBLG1 System for Aerobic, Anaerobic, and Mixed Type Physical Activities. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-1861-p

BibTeX
@article{ADENIS2026,
  author = {ADENIS, ALICE and LACHAL, SYLVAIN and GAUTHIER, PIERRE and GIMENEZ, PAUL and DESIR, CHESNER and ROUX-MALLOUF, THIBAULT LE and HUNEKER, ERIK and BENHAMOU, PIERRE Y.},
  title = {1861-P: Performance of DBLG1 System for Aerobic, Anaerobic, and Mixed Type Physical Activities},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-1861-p}
}
Kostenlos starten →